In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Lumexa Imaging Holdings Inc (NASDAQ: LMRI) closed at $15.82 down -5.16% from its previous closing price of $16.68. In other words, the price has decreased by -$5.16 from its previous closing price. On the day, 0.7 million shares were traded. LMRI stock price reached its highest trading level at $17.23 during the session, while it also had its lowest trading level at $15.24.
Ratios:
For a deeper understanding of Lumexa Imaging Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 0.99. In the meantime, Its Debt-to-Equity ratio is 8.10 whereas as Long-Term Debt/Eq ratio is at 7.88.
On January 05, 2026, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $22.
On January 05, 2026, Raymond James started tracking the stock assigning a Outperform rating and target price of $23.Raymond James initiated its Outperform rating on January 05, 2026, with a $23 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LMRI now has a Market Capitalization of 1496028672.
Stock Price History:
Over the past 52 weeks, LMRI has reached a high of $19.45, while it has fallen to a 52-week low of $15.81. The 50-Day Moving Average of the stock is -10.71%, while the 200-Day Moving Average is calculated to be -10.71%.
Shares Statistics:
For the past three months, LMRI has traded an average of 1.02M shares per day and 753410 over the past ten days. A total of 625.71M shares are outstanding, with a floating share count of 94.22M.
Earnings Estimates
As of right now, 6 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.16, with high estimates of $0.19 and low estimates of $0.14.
Analysts are recommending an EPS of between $0.26 and -$0.17 for the fiscal current year, implying an average EPS of -$0.04. EPS for the following year is $0.73, with 7.0 analysts recommending between $0.89 and $0.61.
Revenue Estimates
For the next quarter, 7 analysts are estimating revenue of $255.55M. There is a high estimate of $256.4M for the next quarter, whereas the lowest estimate is $254M. Based on 7 analysts’ estimates, the company’s revenue will be $1.07B in the next fiscal year. The high estimate is $1.09B and the low estimate is $1.06B.
